Personalized tamoxifen dosing for breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether adjusting the dose of tamoxifen based on your body's processing can improve treatment for hormone-sensitive breast cancer. It aims to find the best dose for you while keeping side effects manageable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary breast cancer and your doctor recommends tamoxifen therapy (with or without a medication to stop ovarian function).
- You are premenopausal or perimenopausal (still having periods or transitioning to menopause).
- Your daily activities are not severely limited (ECOG score 0–2).
- You agree to use non-hormonal birth control during the study.
- You have not taken tamoxifen, endoxifen, or aromatase inhibitors before.
- You do not have a history of blood clots, bleeding disorders, or certain eye conditions (like macular degeneration, retinal issues, severe cataracts, or glaucoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether adding alternative or complementary supports can improve how well people stick with tamoxifen treatment for early hormone-related breast cancer. If it helps adherence, it may help people benefit more reliably from their prescribed therapy.
This trial compares two low-dose medications, exemestane and tamoxifen, to see which is better at preventing breast cancer in postmenopausal women who have a higher risk. You would take one of these pills daily for a few years, and the study will check how well it works and what side effects occur.
This trial tests two low-dose hormone blockers (exemestane and tamoxifen) to see which one is better at preventing breast cancer in postmenopausal women who are at high risk. You will have a 50% chance of getting either drug, and the study will follow you for several years to compare their effectiveness and side effects.
This trial tests if giving hormone-blocking pills before surgery can help guide which treatments you need after surgery. It is for premenopausal women with early-stage, hormone-sensitive breast cancer.
This trial tests whether switching to a different aromatase inhibitor or using standard treatments works better for managing side effects in breast cancer survivors. It aims to help you stay on hormone therapy longer with fewer discomforts.
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.